GAST and pancreatic neoplasm: In comparison, the patients with elevated serum gastrin concentrations of >180 pg/mL had a FERAD ratio of 66,511 ± 102,587, n = 6, and the patients with pancreatic cancer had a FERAD ratio of 35,229 ± 56,684, n = 7.